Firecrest Clinical, an eClinical solution provider, announces the appointment of Alan Horgan as CEO.
Horgan began working in the drug development sector in 1997 and moved to the United States in 2000. In 2009, he began working with Firecrest to establish their operations in the U.S. and globalize their business.
Possessing many years of experience within the pharmaceutical industry, Horgan has held several high-level positions in the healthcare clinical research organization (CRO) sector, most notably at MDS Pharma Services as group vice president, late stage development, and at Covance as corporate senior vice president and president, clinical development. His broad experience of clinical development and the challenges of running complex global clinical trials make him well suited to build on the strong foundations that Firecrest has established in Europe and the U.S.
Horgan stated that he has “found a company that truly addresses the needs of the principal investigators and their busy site staff. It is easy to forget that, as trials continue to become more complex, finding suitable patients and recording many thousands of pieces of data becomes increasingly difficult. This continues to be a challenge despite the introduction of various technologies designed ostensibly in recent years to simplify the process.”